Latest article
Fierce Pharma Asia—AstraZeneca-Junshi PD-1 deal; Takeda’s $1.2B diabetes selloff, Ovid epilepsy collab pullout
In a strangely structured deal, AstraZeneca has nationwide licensed Junshi Biosciences' PD-1 inhibitor for only one indication in China. Takeda continued to sell...
11 Health: Again yard workout routines
11 Fitness: Backyard Exercises
Updated: 4:51 PM EDT June 6, 2021
Hide transcript Show transcript
COMPLETED AFTERNOON. WE'RE BACK TO LER0S 8OW ON FRIDAY. JENNIFER:...
Important Oils Market Rugged Growth Foreseen by 2030
Latest research report on Market 2020 Essential oils Published by InsightSLICE, starts with the market description, executive report, segmentation and classification. ...